Rapidly Growing Nanotechnology Firm Launches New Identity As MIP DiscoveryGemma Cann2024-11-28T14:53:30+00:00May 24th, 2022|Colworth Park, News|
Symrise Opens Innovation Lab Located At Colworth Science ParkGemma Cann2024-11-28T15:21:14+00:00December 15th, 2021|Colworth Park, News|
Community Dental Services Shortlisted As Finalists In The Oral Health AwardsGemma Cann2024-11-28T15:22:41+00:00October 15th, 2021|Colworth Park, News|
Seasoned Medical Device Company Boss, Mark Harwood Joins Camstent As CEOGemma Cann2024-11-28T15:22:59+00:00August 25th, 2021|Colworth Park, News|
MIP Diagnostics Secures £5.1m In Funding To Expand Commercial Operations And ProductionGemma Cann2024-11-28T15:23:16+00:00August 25th, 2021|Colworth Park, News|
New Antibiotic Resistance Test Developed By AGPlus DiagnosticsGemma Cann2024-11-28T15:23:59+00:00August 25th, 2021|Colworth Park, News|
Concepta Inks Global License Agreement With Abingdon HealthGemma Cann2024-11-28T15:24:29+00:00August 25th, 2021|Colworth Park, News|
Stream Bio Works With MIP Diagnostics On Rapid Diagnostic And Mass Screening Test For COVID-19Gemma Cann2024-11-28T15:24:51+00:00August 25th, 2021|Colworth Park, News|
Veravas And MIP Diagnostics Announce International Agreement For Improved DiagnosticsGemma Cann2024-11-28T15:25:07+00:00August 25th, 2021|Colworth Park, News|
AgPlus Developing Two Assays To Support The COVID-19 Diagnostic EffortGemma Cann2024-11-28T15:27:12+00:00August 25th, 2021|Colworth Park, News|
